These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34941639)

  • 1. Therapeutic Options for Childhood Absence Epilepsy.
    Rinaldi VE; Di Cara G; Mencaroni E; Verrotti A
    Pediatr Rep; 2021 Dec; 13(4):658-667. PubMed ID: 34941639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
    Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological impairment in childhood absence epilepsy: Review of the literature.
    Verrotti A; Matricardi S; Rinaldi VE; Prezioso G; Coppola G
    J Neurol Sci; 2015 Dec; 359(1-2):59-66. PubMed ID: 26671087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pediatric epilepsy: expert opinion, 2005.
    Wheless JW; Clarke DF; Carpenter D
    J Child Neurol; 2005 Dec; 20 Suppl 1():S1-56; quiz S59-60. PubMed ID: 16615562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide.
    Wallace SJ
    Epilepsy Res; 1998 Jan; 29(2):147-54. PubMed ID: 9477147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses.
    Campos MSA; Ayres LR; Morelo MRS; Carizio FAM; Pereira LRL
    Int J Clin Pharm; 2018 Jun; 40(3):589-598. PubMed ID: 29744790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine in typical absence epilepsy.
    Buoni S; Grosso S; Fois A
    Brain Dev; 1999 Jul; 21(5):303-6. PubMed ID: 10413016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Capparelli EV; Adamson PC;
    N Engl J Med; 2010 Mar; 362(9):790-9. PubMed ID: 20200383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of refractory idiopathic epilepsies.
    Perucca E
    Epilepsia; 2001; 42 Suppl 3():31-5. PubMed ID: 11520320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two epileptic syndromes, one brain: childhood absence epilepsy and benign childhood epilepsy with centrotemporal spikes.
    Cerminara C; Coniglio A; El-Malhany N; Casarelli L; Curatolo P
    Seizure; 2012 Jan; 21(1):70-4. PubMed ID: 22000044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Childhood absence epilepsy: An update].
    Garzon P; Lemelle L; Auvin S
    Arch Pediatr; 2016 Nov; 23(11):1176-1183. PubMed ID: 27683026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes.
    Mastroianni G; Ascoli M; Gasparini S; Brigo F; Cianci V; Neri S; Russo E; Aguglia U; Ferlazzo E
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1427-1433. PubMed ID: 34289757
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiepileptic drugs in North America].
    Akiyama T; Otsubo H
    Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood absence epilepsy and benign epilepsy with centro-temporal spikes: a narrative review analysis.
    Verrotti A; D'Alonzo R; Rinaldi VE; Casciato S; D'Aniello A; Di Gennaro G
    World J Pediatr; 2017 Apr; 13(2):106-111. PubMed ID: 28101769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of partial seizures in childhood : an overview.
    Coppola G
    CNS Drugs; 2004; 18(3):133-56. PubMed ID: 14871158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood Absence Epilepsy evolving to Eyelid Myoclonia with Absence Epilepsy.
    Galli J; Micheletti S; Malerba L; Fazzi E; Giordano L
    Seizure; 2018 Oct; 61():1-3. PubMed ID: 30029089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant drugs for generalized tonic-clonic epilepsy.
    Coppola G; Piccorossi A; Operto FF; Verrotti A
    Expert Opin Pharmacother; 2017 Jun; 18(9):925-936. PubMed ID: 28481729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.